$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
FDA授予LP-184治疗胰腺癌的孤儿药资格
2025-10-19 11:44:20
Check Details
Napabuksi主要用于治疗什么疾病?国内上市了吗?
2025-10-19 11:44:20
Check Details
孤儿药Napabuksi获FDA批准上市了吗?怎么购买?
2025-10-19 11:44:20
Check Details
重磅!索托拉西布治疗KRASxa0G12C突变型晚期胰腺癌效果令人鼓舞
2025-10-19 11:44:20
Check Details
索托拉西布对KRAS G12C突变型晚期胰腺癌有疗效
2025-10-19 11:44:20
Check Details
胰腺癌治疗新发现!患者来源的类器官,为治疗选择提供新希望!
2025-10-19 11:44:20
Check Details
肺癌临床治疗的利器,厄洛替尼上市十多年依旧是主力军
2025-10-19 11:44:20
Check Details
瑞博西林的使用方法及副作用看这一篇就够了!
2025-10-19 11:44:20
Check Details
胰腺癌常见的并发症有哪些?
2025-10-19 11:44:20
Check Details
胰腺癌会导致多种并发症
2025-10-19 11:44:20
Check Details
吉西他滨+厄洛替尼常见的不良反应有哪些?
2025-10-19 11:44:20
Check Details
厄洛替尼治疗胰腺癌效果怎么样?
2025-10-19 11:44:20
Check Details
1
2
...
6311
6312
6313
6314
6315
6316
6317
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
2
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
3
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
4
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
5
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
6
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
7
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
8
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
9
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
10
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
11
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
12
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial